Testing effectiveness (Phase 2)Study completedNCT00034242
What this trial is testing
High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration
Who this might be right for
Spinocerebellar Degenerations
National Institute of Neurological Disorders and Stroke (NINDS) 20